Early Innovation Programs Lead Betty Zhang oversees MedTech Actuator’s early innovation programs — MedTech Actuator Origin and Menzies Scholarship and Fellowship for researchers innovating in MedTech, HealthTech and BioTech.
As a recent graduate from the University of Melbourne with a Bachelor of Science (Chancellor’s Scholar) in Biotechnology (specialising in Immunology), Betty brings her passion for innovation and the desire to bridge the gap between academia and industry to the role. Her passion for biomedical science started in high school, where she had the opportunity to work in research laboratories across Victoria. Betty was the first Australian scholar in the Clark Scholars high school program where she got a chance to conduct 8 weeks of neuroscience research at Texas Tech University.
Back in 2018, Betty was also selected as the inaugural Graeme Clark Oration Young Woman Ambassador and successfully organised the first high school neuroscience conference for over 130 students. Betty’s passion for science continued throughout her university years, where she worked as a research assistant at the Walter and Eliza Hall Institute, the Disability Officer Bearer in the University of Melbourne Student Union and as a Fundamental Equities Analyst for biotechnology stocks at Churchill Asset Management.
Discovering her passion for innovation and the desire to bridge the gap between academia and industry she took a management role rather than pursuing her ambition to become a clinician-scientist. In her role as Early Innovation Programs Lead, Betty can realise her passion as the role straddles the intersection of so many fields that she is passionate about. She is responsible for leading innovation workshops across Australia to provide actionable advice for researchers and clinicians interested in commercialisation.
“I hope to combine my passion for science, mentoring and finance, especially in leveraging Australia’s capabilities in biomedical innovation”.
Through her role, Betty will be working at the grassroots level of innovation where she will get an opportunity to witness the foundational translation moment for researchers and clinicians to become entrepreneurs.
“I am inspired by the collaborative energy of the MedTech Actuator team and the broader community of foundational partners and collaborators. Everyone is so enthusiastic and optimistic about the opportunities for leveraging Australia’s world-class research capabilities to transform human health”, says Betty.
Looking to the future, Betty is excited about the growth of the MedTech industry in Australia and the increasing focus on diversity and inclusion.
“I am excited about the future of the MedTech Actuator and the broader ecosystem. With the recent growth in the industry and the increasing interest from investors, I am confident that we will see more innovation and growth in the coming years. It is essential that we create an environment that is supportive and inclusive for everyone, and I look forward to contributing to this effort”, says Betty.
Outside of work, Betty co-founded the Melbourne Bioinnovation Student Initiative (MBSI) to support young innovators and entrepreneurs to build multidisciplinary project teams to solve unmet needs in healthcare. She contributed to the executive management of the delivery of projects spanning digital health, AI, synthetic biology and medical devices. As a CEO at MBSI, she hopes to create a community of students interested in applying their skills to create positive change and implement real-world solutions.
We are thrilled to have Betty on our team and look forward to seeing the impact she will make on the MedTech industry in Australia.
Meet our team
More on how the MedTech Actuator team is supporting Asia Pacific’s next wave of health innovators – meet: